---
figid: PMC9440249__12276_2022_837_Fig10_HTML
pmcid: PMC9440249
image_filename: 12276_2022_837_Fig10_HTML.jpg
figure_link: /pmc/articles/PMC9440249/figure/Fig10/
number: Fig. 10
figure_title: Schematic of e-375i elicited anti-PCa effects
caption: Shown is the graphical illustration of the identified pathway of miR-375
  in regulating PCa progression and enzalutamide resistance.
article_title: MicroRNA-375 is a therapeutic target for castration-resistant prostate
  cancer through the PTPN4/STAT3 axis.
citation: Junqing Gan, et al. Exp Mol Med. 2022 Aug;54(8):1290-1305.
year: '2022'

doi: 10.1038/s12276-022-00837-6
journal_title: Experimental & Molecular Medicine
journal_nlm_ta: Exp Mol Med
publisher_name: Nature Publishing Group UK

keywords:
- miRNAs
- Prostate cancer

---
